Michael S Weingarten, M.D.

Medicare Part B Activity

Reported 9,892 Medicare fee-for-service service lines in 2024.

Activity Percentile

97.7%

Rank by Services

15 of 665

Total Services

9,892

Est. Allowed Value

$342,833.31

Dataset Year

2024

Drug Code Share

91.4%

Estimated allowed value reflects Medicare fee-for-service allowed amounts only. It does not include Medicare Advantage, commercial insurance, cash-pay services, or employment compensation.

Peers are grouped by the broader Internal Medicine classification rather than the exact subspecialty label shown elsewhere on the page.

Drug-related HCPCS codes make up 91.4% of reported Medicare services, so the claim mix is dominated by administered-drug billing lines.

Top Clinical Services

• 99214: Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more

  212 services | $25,364.71

• 96413: Administration of chemotherapy into vein, 1 hour or less

  204 services | $24,760.04

• G2211: Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's

  176 services | $2,662.72

• 96415: Administration of chemotherapy into vein, each additional hour

  156 services | $4,073.36

• 96372: Injection of drug or substance under skin or into muscle

  47 services | $643.50

Common Drug-Related Codes

• J1745: Injection, infliximab, excludes biosimilar, 10 mg

  4,202 services | $131,905.52

• J0897: Injection, denosumab, 1 mg

  2,464 services | $63,432.75

• J0129: Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)

  1,975 services | $84,229.78